FDA Gives Voxelotor Accelerated Approval for Kids with Sickle cell disease (SCD)
The U.S. Food and Drug Administration (FDA) has granted accelerated approval of a supplemental New Drug Application (sNDA) for Oxbryta® (voxelotor) tablets for the treatment of Sickle cell disease (SC ...